AXIM Biotechnologies, Inc.
AXIM Biotechnologies, Inc., a leading player in the biotechnology sector, is headquartered in the United States. Founded in 2014, the company has made significant strides in the development of innovative cannabinoid-based products, focusing on areas such as pharmaceuticals, diagnostics, and consumer goods. AXIM is renowned for its unique offerings, including proprietary formulations that leverage the therapeutic potential of cannabinoids. The company’s commitment to research and development has positioned it as a pioneer in the industry, with notable achievements in clinical trials and product launches. With a strong market presence, AXIM Biotechnologies continues to drive advancements in cannabinoid science, aiming to improve health outcomes and enhance quality of life for patients worldwide.
DitchCarbon Score
How does AXIM Biotechnologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AXIM Biotechnologies, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AXIM Biotechnologies, Inc.'s reported carbon emissions
AXIM Biotechnologies, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. As of now, the company has not disclosed any absolute emissions figures, including Scope 1, 2, or 3 emissions. Additionally, there are no documented climate commitments or initiatives aimed at reducing carbon emissions. In the absence of specific data, it is unclear how AXIM Biotechnologies is addressing climate change or its carbon footprint within the biotechnology industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AXIM Biotechnologies, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
